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We have devised an immunological procedure to separate cells on the basis of
expression of mouse mammary tumor virus (MMTV) gene products. Plastic petri
dishes coated with specific antibodies against MMTV proteins bind cells with an
efficiency that correlates with the level of MMTV gene expression. Glucocorti-
coid-sensitive mouse thymoma cell line W7 was infected with MMTV. Clones
from the infected population retain the relatively slow cytolytic glucocorticoid
response and, in addition, exhibit a rapid induction of MMTV-specific RNA and
proteins. By combining our immunological selection with the selection for
resistance to hormone-mediated cytolysis, we have isolated variant cells which
are resistant to the cytotoxic effect of glucocorticoids but which retain the
induction of viral gene products and must therefore have a functional glucocorti-
coid receptor protein.
Like the immunocytes from which they were
derived (4), some mouse thymoma cell lines are
killed by exposure to physiological concentra-
tions of glucocorticoid hormones for 1 to 3 days
(9, 10). Although the mechanism of the killing
response is not well defined, the hormone-in-
duced cell death provides a strong selection for
hormone-insensitive variants. However, the
complexity of the killing response and the ab-
sence of an identifiable, induced gene product
make the biochemical characterization of vari-
ant phenotypes difficult. Selection for hormone
resistance has yielded several phenotypic class-
es of variants in the glucocorticoid receptor
protein (11, 14, 29). These have been extremely
useful, but other classes of variants would be of
obvious interest.
To facilitate the genetic analysis of glucocorti-
coid responsiveness in lymphoid cells, we have
infected them with mouse mammary tumor virus
(MMTV), which establishes itself as a stably
integrated provirus with glucocorticoid-respon-
sive gene expression (17, 26). The infected cells
exhibited two independent glucocorticoid re-
sponses: the relatively slow cytolytic response
and the rapid stimulation of MMTV RNA and
protein synthesis. To exploit this phenotype for
genetic analysis, we have developed an immuno-
logical selection to separate cells on the basis of
differential expression of viral proteins on the
cell surface. In this report, we describe the
characteristics of the MMTV-infected lymphoid
cells, the details of our immunological selection
procedure, and the selection of variant cells with
a novel phenotype: they have lost the cytolytic
response to glucocorticoids but retain the ability
to induce MMTV gene products and must there-
fore have a functional glucocorticoid receptor
protein.
MATERIALS AND METHODS
Materials. Dulbecco modified essential medium and
horse serum were purchased from Flow Laboratories,
Inc. Serum was heat inactivated by incubating 500-ml
bottles for 30 min at 56°C and then was clarified by
centrifugation. Noble agar was obtained from Difco
Laboratories; polystyrene bacterial petri dishes were
from Falcon Plastics; ethyl methane sulfonate and
dexamethasone (DEX) were from Sigma Chemical
Co.; [5,6-3H]uridine was from ICN Pharmaceuticals,
Inc.; and [a-32P]dTTP was from New England Nuclear
Corp. DNA clone pMTV1 (25) contains the entire
MMTV genome (except for a small deleted portion),
inserted into the EcoRI site of pBR322.
Cells and tissue culture. All cultures were grown in
Dulbecco modified essential medium supplemented
with 10o heat-inactivated horse serum and without
antibiotics. W7.2 is a randomly chosen subclone of the
BALB/c mouse thymoma-derived cell line WEHI7
(10). GR-A3 is a cloned cell line derived from a
mammary tumor in the GR strain of mouse (16). W7
cells were cloned on top of 0.5% Noble agar in
Dulbecco modified essential medium containing 15%
horse serum (14).
For growth curves, cells were counted with a hema-
cytometer and an inverted phase-contrast microscope.
Live cells are large, turgid, translucent spheres that
are easily distinguished from dead cells, which are
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PANNING FOR GLUCOCORTICOID RESPONSE VARIANTS 1311
shrunken, irregular in shape, and refractile. Viable cell
counts obtained by using these visual criteria were
identical to those obtained by observing trypan blue
exclusion.
Cells were mutagenized by incubation for 16 h at
37°C in growth medium containing 250 ,ug of ethyl
methane sulfonate per ml. The surviving cells (15%)
were grown for 3 days before use in the selection
experiments.
Infection ofW7 cells with MMTV. The C3H strain of
MMTV in purified, concentrated form was kindly
provided by the Viral Resources Laboratory of the
Frederick Cancer Research Center, Frederick, Md.
GR strain MMTV preparations for infection of cell
cultures were obtained from the 24-h culture superna-
tant of confluent GR-A3 cultures grown in roller
bottles. The frozen supernatant was thawed, centri-
fuged at 500 x g for 10 min to remove cell debris, and
then centrifuged at 50,000 x g for 3 h at 4°C. The viral
pellet from 250 ml of supernatant was suspended in 5
ml of Dulbecco modified essential medium with 10%
horse serum and stored frozen at -70°C until use.
Cells were infected with MMTV (17) by adding 1 ml of
viral concentrate to 1 ml of growth medium containing
107 cells. After 2 h at 37°C, the cell suspension was
diluted 10-fold with fresh growth medium, and after 3 h
more, the cells were washed once with growth medium
and suspended in fresh medium.
Anti-MMTV antibodies. Mouse hybridoma line 8G2,
used in these studies, secretes monoclonal antibodies
against the MMTV protein p27 (D. Ucker, G. Fire-
stone, and K. Yamamoto, personal communication).
Monoclonal antibody preparations were obtained by
growing the 8G2 cells as an ascites tumor in BALB/c
mice. Ascites fluid was harvested aseptically through a
syringe needle, clarified by centrifugation (10 min at
2,000 x g), and stored at -70°C. It was used for the
immunological selection procedure without further
purification.
Preparation of antibody-coated dishes and selection of
cells. The procedure for cell selection was based on the
"panning" technique of Wysocki and Sato (28). All
steps were performed at 4°C or on ice; handling of cells
and solutions was performed aseptically in a Baker
Sterilegard biological safety cabinet. Monoclonal anti-
body preparations against MMTV protein p27 were
diluted with 20 mM Tris-hydrochloride (pH 9.5), and 2
ml of the solution was loaded into each 60-mm bacteri-
al petri dish. The actual dilution (usually ca. 130-fold)
was determined empirically for each ascites fluid prep-
aration. Dishes were incubated overnight at 4°C and, if
not used immediately, were stored with the diluted
antibody solution at -20°C; dishes retained their cell
binding activity for at least a month. Immediately
before use, the antibody-coated dishes were washed
three times with 5 ml of cold PBSS (phosphate-
buffered saline containing 5% heat-inactivated horse
serum), the buffer being removed by aspiration each
time. Cells were prepared for selection by being
washed once by centrifugation with 10 ml of cold
PBSS, resuspended in 2 ml of the same buffer, and
then incubated in an antibody-coated dish at 4°C for 90
min. The number of cells added to each dish depended
on the type of cell being selected. For quantitative
binding studies, fewer than 107 cells were added to
each 60-mm dish. When low cell binding percentages
were expected in a selection procedure, as many as 108
cells were added to each 100-mm dish. At 30 and 60
min after cells were added, the dishes were swirled
gently to redistribute unbound cells. Unbound cells
were removed at 90 min by careful aspiration, and the
dishes were washed gently two times with cold PBSS.
Bound cells were removed by repeatedly squirting 2
ml of cold PBSS onto the bound cells from a Pasteur
pipette until complete resuspension of all bound cells
was achieved. Bound cells were then washed once
with PBSS and resuspended in growth medium. Only
viable cells bind to the antibody-coated dishes; dead
cells and debris do not bind.
The percentage of cells from a clonal population that
bind to antibody-coated dishes is influenced by the
amount of antibody loaded onto the dishes. In addi-
tion, some lots of horse serum interfere with the
binding of cells to the dishes, even though the cell
growth rate, DEX-induced cytolytic response, and the
DEX induction of MMTV RNA synthesis are normal.
Unless stated otherwise below, the serum lot and
antibody concentration used for all selections de-
scribed in this report produced approximately 90%o
binding of DEX-treated W7MG1 cells and less than 1%
binding of control W7MG1 cells.
Selection for DEX resistance. Cell populations were
alternately grown in medium containing 1 ,uM DEX for
36 h and DEX-free medium for several days. Some
MMTV-infected cells (lymphoma lines and other cell
types) grown in DEX for extended periods accumulate
very large numbers of integrated MMTV proviral
sequences by a mechanism that is not clearly under-
stood but appears not to involve production of infec-
tious virions. Such cells often have very high basal
levels of MMTV expression (B. Maler, J. Ring, D.
Peterson, and K. Yamamoto, unpublished data).
When relatively brief periods of DEX treatment (36 h)
were alternated with periods of DEX-free growth, as
in our protocol, the incidence of cells with elevated
basal levels ofMMTV expression was reduced but not
completely eliminated (data not shown).
Measurement of relative intracellular concentrations
and rates of synthesis of MMTV RNA. Total cellular
MMTV RNA content was determined by two different
methods. In Fig. 1 and 2, whole cell RNA from control
or 12-h DEX-treated cells was prepared and analyzed
for relative content of MMTV RNA by Crt analysis as
described by Ringold et al. (19), using MMTV
[3H]cDNA prepared as described previously (18). In
Fig. 3, a rapid, semiquantitative method for measuring
MMTV RNA content of whole cells (D. Peterson and
K. Yamamoto, manuscript in preparation) was used.
A measured number of cells in phosphate-buffered
saline were filtered through a 3-mm chimney onto
Whatman 3MM paper. Cells were lysed in situ by
freezing and thawing, fixed with ethanol-acetic acid
(3:1), washed with 95% ethanol, and dried at room
temperature. The filter was hybridized to pMTV1
[32P]DNA prepared by nick translation (15), washed,
and subjected to autoradiography (21). The dried filter
was then stained with 0.2% Coomassie blue in metha-
nol-acetic acid (7:1) and destained in 95% ethanol. The
stained filter gives an indication of the relative number
of cells fixed to each spot, and the autoradiogram
indicates the relative amount of MMTV RNA on each
spot.
The relative rate of synthesis of MMTV RNA was
determined by nucleic acid filter hybridization analysis
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FIG. 1. Concentration ofMMTV RNA in clones of
infected W7.2. The relative concentration ofRNA was
determined by Crt analysis as described in the text.
Panel A, W7MG1 cells; Panel B, W7M4.12 cells.
Symbols: 0, no DEX treatment; 0, cells treated for 12
h with 1 p.M DEX.
of RNA from pulse-labeled cells. A total of 10' cells
were grown in 5 ml of normal growth medium for 30
min in the presence or absence of 1 p.M DEX; 0.25
mCi of [3H]uridine was added for 15 min, and then
RNA was isolated from the cells (19). The relative
amount ofMMTV RNA in the [3H]RNA preparations
was determined by hybridization to nitrocellulose fil-
ters containing immobilized pMTV1 DNA, as de-
scribed by McKnight and Palmiter (13) and modified
by Ucker et al. (25).
RESULTS
Characterization of MMTV-infected W7 cells.
W7 cells are killed by a 36- to 72-h exposure to
glucocorticoid concentrations as low as 5 nM;
the response is mediated by the glucocorticoid
receptor protein (1). Like all normal BALB/c
cells, W7 cells carry two complete copies of
MMTV proviral DNA as well as a third, incom-
plete copy (5). These endogenous viral genes are
not expressed in W7 or in any normal BALB/c
mouse tissue examined (23, 27).
W7.2 was infected with the C3H strain of
MMTV. In contrast to uninfected W7.2 cells,
MMTV RNA was readily detected in the infect-
ed population after treatment with 1 ,uM DEX
for 12 h. Cell viability was not affected by
exposure to 1 F.M DEX for as much as 14 h, if
cells were promptly returned to DEX-free medi-
um.
Two clones of infected cells (W7MG1 and
W7M4.12) were characterized for their contents
of MMTV RNA and DNA. MMTV RNA was
quantitated by solution hybridization. W7MG1
(Fig. 1A) had a significant level of MMTV RNA
in the absence ofDEX, and after a 12-h hormone
treatment, the steady-state level of viral RNA
increased about 10-fold to a level corresponding
to about 0.07% of total cellular RNA (based on
Crtji2 of 0.02 for pure MMTV RNA). W7M4.12
(Fig. 1B), on the other hand, had no detectable
MMTV RNA in the absence of hormone, and
DEX caused at least a 100-fold induction of viral
100
90
80
= pecenage cell binding
relative concentration of MMTV RNA
_ relative rate of synthesis of MMTV RNA
701_
60
501
401.
30-20.mD JU10'
W7M4.12 W7M4.12 dex W7MG1 W7MG1 dex
CELLS
FIG. 2. Comparison of cell binding to antibody-
coated dishes and MMTV RNA synthesis. The per-
centage of total cells that bind to antibody-coated
dishes was determined as described in the text, using
control cells or cells grown with 1 F.M DEX for 8 h.
Each bar on the graph represents the average of five or
more independent determinations. Variation from the
mean was 5 percentage points or less. Full scale (100
units) on the graph represents 100%o binding of cells.
The relative intracellular concentration of MMTV
RNA was determined by Crt analysis as described in
the text, using RNA from control cells or cells grown
with 1 ,uM DEX for 12 h. Full scale (100 units) on the
graph represents a relative MMTV RNA concentra-
tion of 0.07% of total cell RNA. Each bar represents
the results of one Crt analysis. The relative rate of
MMTV RNA synthesis was determined by filter h-.
bridization analysis of pulse-labeled cell RNA, as
described in the text. Full scale (100 units) on the
graph represents a relative rate of MMTV RNA syn-
thesis of 0.45% of total [3H]RNA. Each bar represents
the average of two determinations; for each value,
variation from the mean was 5 percentage points or
less.
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FIG. 3. Selection of cells with high levels of
MMTV expression from an infected population.
W7M4.12 cells were reinfected with MMTV and sub-
jected to two rounds of petri dish selection for MMTV
expression in the presence ofDEX, as described in the
text. At each step of the procedure, a sample of cells
was treated with DEX for 8 h and analyzed for binding
to an antibody-coated petri dish. The percentage of
total cells that bound to the dish is shown in the left-
hand column. A sample of 106 DEX-treated cells was
also analyzed for MMTV RNA content by the whole
cell filter hybridization technique (see the text). The
middle column shows the autoradiogram of the cell
dots after hybridization with MMTV [32P]DNA. The
right-hand column shows the same cell dots stained
with Coomassie blue.
RNA to a final concentration of about 0.005% of
total cellular RNA.
A Southern blot analysis of cellular DNA (22)
was carried out with EcoRI, which cleaves the
BALB/c endogenous MMTV provirus (5) and
the C3H exogenously acquired provirus (21)
once. In addition to the endogenous MMTV
genes, W7MG1 had 10 copies of proviral DNA,
and W7M4.12 had 8 copies (data not shown).
Correlation of MMTV RNA synthesis with cell
binding to antibody-coated dishes. Our prelimi-
nary observations suggested that some MMTV-
infected W7 cells accumulate virus-specific cell
surface proteins in response to DEX. To exploit
this observation, we adapted a procedure that
employs antibody-coated petri dishes (see
above) to separate cells that are expressing viral
cell surface proteins from cells that are not. To
test the specificity of this procedure, W7.2,
W7M4.12, and W7MG1 cells, grown in the pres-
ence or absence ofDEX, were analyzed by three
parameters: (i) binding to petri dishes coated
with MMTV-specific antibodies, (ii) intracellular
concentrations of MMTV RNA, and (iii) rate of
synthesis of MMTV RNA. Uninfected W7.2
cells (control or DEX-treated) contained no de-
tectable MMTV RNA and exhibited no measur-
able binding to an antibody-coated dish. Howev-
er, W7M4.12 and W7MG1 cells bound to the
dishes, and the amount of binding correlated
with the concentration and rate of synthesis of
MMTV RNA in the cell (Fig. 2). In the absence
of DEX, W7M4.12 cells had a very low level of
MMTV RNA synthesis and did not bind to an
antibody-coated dish, but after DEX treatment,
we saw a 30-fold stimulation in the rate of
MMTV RNA synthesis, and 1% of the cells
bound (background binding was about 0.1%).
For W7MG1, 20o of the cells bound before
DEX treatment, and 97% bound after 8 h in
DEX. In all cases, the percentage of cells that
bound correlated with the level and rate of
synthesis of MMTV RNA in the cell.
Selection of cells with high levels of MMTV
gene expression. To test the feasibility of using
our immunological method to isolate cells with a
rare phenotype from a large population, we
reinfected a culture of 107 W7M4.12 cells with
MMTV virions. Such an infected population was
expected to contain cells with different levels of
MMTV gene expression when treated with
DEX; we applied our immunological selection to
isolate a subpopulation containing relatively
high levels of MMTV gene products. The rein-
fected W7M4.12 cells were grown for 3 days and
treated with DEX for 8 h, and then 6 x 106 cells
were incubated in an antibody-coated dish. The
bound cells (fewer than 105 cells) were removed
from the dish, grown for 6 days in the absence of
DEX, and treated for 8 h with DEX, and 6 x 106
cells were subjected to a second round of the
immunological selection. Again, antibody-
bound cells were removed and grown without
DEX. At each step of the selection scheme, a
sample of cells was treated with DEX for 8 h and
used to determine the percentage of cells that
would bind to an antibody-coated dish; the intra-
cellular MMTV RNA concentration of each
DEX-treated population was also measured by
the whole cell filter hybridization procedure
described above.
Before the reinfection, W7M4.12 cells bound
very poorly (2%) to an antibody-coated dish and
contained low levels of MMTV RNA when
induced with DEX (Fig. 3). After reinfection,
there was no change in the binding of the DEX-
treated cells to an antibody-coated dish. Appar-
ently, only a very small fraction of the reinfected
cells made enough MMTV proteins to bind
strongly to the dish. Each round of immunologi-
cal selection enriched the population for cells
expressing high levels of MMTV RNA and
MMTV cell surface proteins (Fig. 3). Thus, the
selection procedure appears to be suitable for
separating a small number of cells with high
MMTV expression from a large population of
cells with generally low levels of MMTV gene
expression.
Selection of DEX-resistant, MMTV-inducible
variants. W7MG1 was chosen as the parent cell
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1314 DANIELSEN, PETERSON, AND STALLCUP
line for selection of variants resistant to the
cytolytic effect of glucocorticoids but retaining
the hormone-mediated stimulation of MMTV
gene expression. W7MG1 cells bound well
(90%) to MMTV antibody-coated petri dishes
after DEX treatment, but did not bind (-0.1%)
without DEX treatment. An ethyl methane sul-
fonate-treated population (108 cells) was grown
with DEX for 8 h and then was distributed
among four 100-mm antibody-coated dishes; the
unbound cells were discarded. To select for
DEX resistance, the bound cells were removed
from the dish and incubated in medium with
DEX for an additional 28 h before being placed
in medium without DEX. To remove cells with
elevated basal levels of MMTV expression (see
above), the selected populations were grown for
at least 10 generations in the absence of DEX
and then were exposed to antibody-coated dish-
es (107 cells on three dishes). This time, bound
cells were discarded, and the unbound cells
were treated with DEX for 8 h and again select-
ed for MMTV expression. At this point, after
one complete cycle of the selection protocol,
less than 5% of the DEX-resistant population
bound to the antibody-coated dish after DEX
treatment. After four cycles of selection, the
resulting population appeared to be composed
mostly of cells that were DEX resistant and
inducible for MMTV expression. Clones of this
population were obtained as described above for
analysis of phenotype.
A second approach was used to obtain DEX-
resistant, MMTV-inducible variants from the
uninfected W7.2 clone. An ethyl methane sulfo-
nate-mutagenized population of 108 W7.2 cells
was repeatedly alternated between growth medi-
um containing 1 ,uM DEX for 36 h and growth
medium without DEX for several days; after
four such cycles, a DEX-resistant population
was obtained. Based upon previous studies (11,
14, 29), we expected the majority of these cells
to be receptor variants. Furthermore, we as-
sumed that some cells with lesions affecting
components other than the receptor protein
should still be able to carry out other glucocorti-
coid responses. To identify potential variants of
this type, we infected the DEX-resistant popula-
tion with GR strain MMTV, treated the cells
with DEX for 8 h, and then used antibody-
coated dishes to select for cells with high levels
of MMTV expression. The bound cells were
removed, propagated, and reselected for DEX-
inducible MMTV expression. After three rounds
of selection, random clones were obtained from
the selected population for analysis.
Phenotype analysis of variant dones. Random
clones from the two selected populations de-
scribed above were characterized for growth
rate in the presence and absence ofDEX and for
the ability to bind to an antibody-coated dish
before and after an 8-h DEX treatment. Figure 4
and Table 1 show the growth curves and anti-
body-binding data for W7MG1 and three of the
DEX-resistant, MMTV-inducible variants.
Wild-type W7 and W7MG1 cells underwent cy-
tolysis when treated with 1 ju.M or 100 nM DEX
for 36 h. MGlR11, MG1R198, and W7.2R191
represent three different degrees of DEX resist-
ance found among the variants (Fig. 4).
MGlR11, derived from W7MG1, was fully DEX
resistant, that is, it had identical growth rates in
the presence or absence of 1 FtM DEX.
MG1R198, also derived from W7MG1, was
killed by 1 ,uM DEX (although more slowly than
the parent W7MG1), but it grew at a reduced
rate in 100 nM DEX. W7.2R191, derived from
W7.2, was growth inhibited by 1 ,uM DEX but
remained viable for over a week before undergo-
ing cytolysis. Quantitative measurements of cell
binding to antibody-coated dishes (Table 1)
showed that all three DEX-resistant variants in
Fig. 4 had DEX-inducible MMTV expression.
The elevated basal level ofMMTV expression in
MGlR11 may indicate that this clone has ac-
quired additional copies of the viral genome, as
discussed above. MG1R198 had a reduced level
of DEX-induced MMTV expression; because
this clone was only partially resistant to DEX, it
may have reduced levels of glucocorticoid re-
ceptors. Characterization of the glucocorticoid
receptor levels in these and other variant clones
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FIG. 4. Growth curves of parental cells and three
DEX-resistant, MMTV-inducible variants. Each clone
was grown in the absence or presence of DEX. Only
viable cells were counted, as described in the text.
Symbols: 0, no DEX; *, 100 nM DEX; *, 1 FM
DEX.
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TABLE 1. Binding of parental and DEX-resistant
clones to antibody-coated dishes
% Bound cells'
Clone
-DEX +DEX
W7MG1 <1 87
MGlRll 24 62
MG1R198 <1 13
W7.2R191 2 85
a Cells of each clone were grown without DEX
(-DEX) or with 1 ,uM DEX (+DEX) for 8 h; the
percentages of control and DEX-treated cells that
bound to antibody-coated dishes were determined as
described in the text.
with the same phenotype is currently in pro-
gress. DEX inducibility of MMTV RNA synthe-
sis in some DEX-resistant clones was verified by
pulse-labeling whole cells with [3H]uridine and
measuring MMTV [3H]RNA by filter hybridiza-
tion (data not shown).
Table 2 shows a summary of the phenotypes
of all of the clones examined from the final
selected populations. Approximately one-third
of the clones selected from the W7MG1 parent
line had the desired phenotype: MMTV induc-
ible and either fully or partially DEX resistant.
The fraction was lower for the W7.2 selection,
but several clones of the desired phenotype were
obtained. The remainder of the clones examined
either had the parental phenotype (MMTV in-
ducible, DEX sensitive) or had lost both re-
sponses (MMTV uninducible, DEX resistant).
DISCUSSION
We have developed an immunological proce-
dure for fractionating cultured mouse lymphoma
cells according to their ability to bind to petri
dishes coated with a monoclonal antibody
against MMTV cell surface proteins. The proce-
dure is technically simple to perform and re-
quires no sophisticated instrumentation. Very
large populations of cells can be processed rap-
idly (in about 2 h). As many as 5 x 107 cells can
be bound to a 100-mm dish. When a population
contains a low percentage of cells that will bind
to the dishes, 108 cells can be loaded into each
100-mm dish without reducing the efficiency of
binding of antigen-positive cells. Relatively high
levels of expression of MMTV functions are
required for efficient binding to the antibody-
coated dish.
The monoclonal antibody preparation we
have used is specific for MMTV protein p27 (D.
Ucker, G. Firestone, and K. Yamamoto, per-
sonal communication). In the MMTV vinon, p27
is part of the nucleoprotein core and is not
accessible to antibodies (20) or to iodination (24)
unless the virion is disrupted with detergents.
Callis and Ritzi (3) reported that p27 in whole,
cultured mouse mammary tumor cells is not
accessible to antibodies. In contrast, our results
indicate that p27 in whole, MMTV-infected W7
cells can interact with antibodies. The analogous
capsid protein from another retrovirus, murine
leukemia virus, has also been observed on the
outer surface of infected lymphoid cells (2).
Using a fluorescence-activated cell sorter and
antibodies against MMTV envelope glycopro-
tein gp52, Grove et al. (7) have devised an
immunological procedure for obtaining gluco-
corticoid response variants of MMTV-infected
HTC cells. As was the case in our studies, they
succeeded in isolating variants that had lost
some glucocorticoid responses but retained oth-
ers (8). The cell sorter can effectively discrimi-
nate lower levels of antigen than can our petri
dish method; however, the processing of 108 or
more cells, which is easily and quickly accom-
plished with petri dishes, would require many
hours and considerable expense with a cell sort-
er.
By choosing the nonbinding cell fraction from
a DEX-treated population, our immunological
technique can be used to select cells that have
lost MMTV inducibility. The efficiency of selec-
tion for antigen-negative cells is lower due to
incomplete binding of some antigen-positive
cells; nevertheless, repeated rounds of selection
have eventually yielded noninducible cells from
a mutagenized population of W7MG1 cells (un-
published data). The selection for nonbinding
cells provides an alternative to the antibody-
mediated complement lysis technique for obtain-
TABLE 2. Summary of clone phenotypes from
populations enriched for DEX-resistant, MMTV-
inducible cellsa
parent Total no. No. of clones of the following type:
cell line of clones MMTV' MMTV' MMTV' MMTVUexamined DEXr DEXPr DEX' DEXr
W7MG1 164 24 27 22 91
W7.2 26 1 2 10 13
a Random clones were obtained from the final se-
lected populations as described in the text. Each clone
was assayed for DEX resistance by growth curve
analysis with various DEX concentrations and for
MMTV inducibility by binding of control and 1 ,LM
DEX-treated cells to antibody-coated dishes. The
number of clones representing each phenotype is listed
in the table. Abbreviations: MMTV', DEX-inducible
MMTV expression; MMTV", MMTV expression un-
inducible by DEX; DEXr, DEX resistant: no growth
inhibition by 1 AjM DEX; DEXPr, partially resistant to
DEX: growth inhibition or cytolysis with 1 AM DEX,
but little or no growth inhibition by 100 nM DEX;
DEXS, DEX sensitive: killed within 2 to 3 days by 100
nM DEX.
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1316 DANIELSEN, PETERSON, AND STALLCUP
ing antigen-negative variants (6, 12). The anti-
body-coated petri dish method may prove useful
as a positive or negative selection for genetic
studies involving other antigens found in rela-
tively large numbers on the cell surface.
The immunological procedure described in
this report was used to isolate rare MMTV-
inducible cells from a large DEX-resistant popu-
lation. Because they retain the glucocorticoid
receptor-mediated induction of MMTV gene
products, these cells must possess functional
glucocorticoid receptor proteins. They therefore
define a novel class of glucocorticoid-resistant
lymphoid cells.
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